Study on the Association Between Vitamin C Deficiency and Diarrhea in Children
NCT ID: NCT05328037
Last Updated: 2026-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
288 participants
OBSERVATIONAL
2022-04-25
2024-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of this study is to assess the impact of vitamin C deficiency on diarrheal infection in children aged 2 to 5 years in countries with a high diarrheal rate. This pilot case-control study will be conducted in metropolitan France, Africa and South America. This question will be addressed by comparing vitamin C levels in children with diarrhea, regardless of the infectious agent, to levels in age- and sex-matched controls.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM
NCT00388921
Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function
NCT01583972
Effectiveness of Vitamin C Supplementation in Treatment of Rickets
NCT05310760
Novel Isotope Dilution Technique to Assess Vitamin A Status
NCT03000543
Nutritional Management of Children With Chronic Diarrhea
NCT01812629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of this study is to assess the impact of vitamin C deficiency on diarrheal infection in children aged 2 to 5 years in countries with a high diarrheal rate. This pilot case-control study will be conducted in metropolitan France, Africa and South America. This question will be addressed by comparing vitamin C levels in children with diarrhea, regardless of the infectious agent, to levels in age- and sex-matched controls.
The study aims at (i) determining whether vitamin-deficiency may occurs in children living in developing countries and at (ii) determining the plasma vitamin A, C and E concentrations in children suffering of diarrheal diseases.
A total of 360 children will participate to the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute diarrhea cases
Children with acute diarrhea defined as at least 3 loose or watery stools per day for at least 3 consecutive days and up to 10 consecutive days
Blood sample collection
Blood sample collection for dosage of vitamin C
Chronic diarrhea cases
Children with chronic diarrhea defined as 3 or more loose or liquid stools per day for at least 4 weeks
Blood sample collection
Blood sample collection for dosage of vitamin C
Controls
Children without fever or signs of infection or ongoing diarrhea
Blood sample collection
Blood sample collection for dosage of vitamin C
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample collection
Blood sample collection for dosage of vitamin C
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no fever
* no sign of infection
-Children suffering from chronic diarrhea defined by the emission of at least 3 soft or liquid stools per day for at least 4 weeks.
-Children suffering from acute diarrhea defined as 3 or more loose or watery stools per day for at least 3 consecutive days and up to 10 consecutive days.
Exclusion Criteria
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Malnutrition
* Diarrhea
* Fever
* Positive malaria rapid diagnostic test (Africa)
* Child currently being breastfed
Chronic diarrhea cases :
* Suspected or diagnosed infectious diseases
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Positive malaria rapid diagnostic test (Africa)
* Antibiotic treatment prescribed within 10 days prior to sampling
* Nutritional supplements in the three months prior to sampling
* Vitamin C supplementation in the last 3 months prior to blood collection
* Child currently being breastfed
Acute diarrhea cases :
* Malnutrition
* Suspected or diagnosed infectious diseases
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Positive malaria rapid diagnostic test (Africa)
* Antibiotic treatment prescribed within 10 days prior to sampling
* Nutritional supplements in the three months prior to sampling
* Vitamin C supplementation in the last 3 months prior to blood collection
* Child currently being breastfed
18 Months
60 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cochin
OTHER
University of Copenhagen
OTHER
Institut Pasteur
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre Manirakiza, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Institut Pasteur de Bangui, Centrafrican Republic
Thomas Blanc, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hopital Necker Paris, France
Jean-Chrysostome Gody, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Complexe Pédiatrique de Bangui, Centrafrican Republic
Emilie Huguon, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Térritorial Gaston Bourret, New Caledonia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complexe Pédiatrique
Bangui, , Central African Republic
Hopital Necker
Paris, , France
Centre Hospitalier Territorial Gaston Bourret
Noumea, , New Caledonia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB number : 2021-A00632-39
Identifier Type: OTHER
Identifier Source: secondary_id
2020-063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.